Dog-Assisted Therapy for Children and Adolescents With Fetal Alcohol Spectrum Disorders a Randomized Controlled Pilot Study.

Objective: The rationale of this study was to evaluate the efficacy of dog-assisted therapy (DAT) combined with pharmacological treatment in children and adolescents with fetal alcohol spectrum disorder (FASD).

Method: We conducted a randomized, rater-blinded, controlled pilot trial in a cohort of 33 children and adolescents with FASD. Participants were randomly assigned either to DAT group ( = 17) or Treatment as Usual (TAU control group) ( = 16).

Results: Of the initial 39 participants enrolled, 33 completed treatment. A mixed-effects model analysis revealed that participants who were assigned to the DAT group experienced significantly improvements on social skills (SSIS-P social skills: = 0.02, = 0.8), reductions on externalizing symptoms (CBCL externalizing: = 0.03; = 0.56), and lower scores on FASD severity (CGI-S clinician: = 0.001, = 0.5).

Conclusion: DAT is a promising adjunctive treatment for children and adolescents with FASD.

Clinical Trial Registration: Dog-assisted therapy for children and adolescents with fetal alcohol spectrum disorders: a randomized controlled pilot study; http://clinicaltrials.gov/, identifier NCT04038164.